TITLE:
Reversal of Ventricular Remodeling With Toprol-XL

CONDITION:
Heart Failure, Congestive

INTERVENTION:
Seloken ZOK/Toprol-XL

SUMMARY:

      The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in
      asymptomatic heart failure subjects will improve their heart structure and thus prevent the
      progression to symptomatic disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Diagnosis of stable asymptomatic heart failure.

          -  Documented ejection fraction less than 0.40.

          -  Must be able to comply with all study procedures.

        Exclusion Criteria:

          -  Taken B-blocker therapy for longer than 1 week within 6 months prior to
             randomization.

          -  Have heart problems that would not allow B-blocker therapy.

          -  Receiving B-blockers therapy for any medical reason including topical B-blockers that
             might cause systemic absorption (e.g., glaucoma).

          -  Undergone certain heart surgeries, such as, prior heart transplant or
             cardiomyoplasty.

          -  Have certain heart diseases.

          -  Pregnant or breast feeding.

          -  Unlikely to survive.
      
